Cytochrome P-450 CYP3A Inhibitors

Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole.

Drug metabolism and pharmacokinetics 29338933

This study was conducted to estimate in vivo inhibition constant (Ki) of ketoconazole on renal P-glycoprotein (P-gp) using human drug-drug interaction (DDI) study result of fesoterodine and ketoconazole. Fesoterodine is a prodrug which is extensively...

ATP Binding Cassette Transporter, Subfamily B, Member 1 Benzhydryl Compounds Cross-Over Studies Cytochrome P-450 CYP3A Inhibitors Drug Interactions Humans Ketoconazole Kidney Liver Male Models, Biological Muscarinic Antagonists

View on PubMed DOI

Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks.

SAR and QSAR in environmental research 25588022

P-glycoprotein (P-gp) is an ATP binding cassette (ABC) transporter that helps to protect several certain human organs from xenobiotic exposure. This efflux pump is also responsible for multi-drug resistance (MDR), an issue of the chemotherapy approac...

ATP Binding Cassette Transporter, Subfamily B Computer Simulation Cytochrome P-450 CYP3A Inhibitors Databases, Chemical Drug Resistance, Multiple Neural Networks, Computer Structure-Activity Relationship

View on PubMed DOI

Application of Deep Neural Network Models in Drug Discovery Programs.

ChemMedChem 34596968

In silico driven optimization of compound properties related to pharmacokinetics, pharmacodynamics, and safety is a key requirement in modern drug discovery. Nowadays, large and harmonized datasets allow to implement deep neural networks (DNNs) as a ...

Cytochrome P-450 CYP3A Cytochrome P-450 CYP3A Inhibitors Deep Learning Dose-Response Relationship, Drug Drug Discovery Factor Xa Factor Xa Inhibitors Humans Molecular Structure Structure-Activity Relationship

View on PubMed DOI

Dietary Inhibitors of CYP3A4 Are Revealed Using Virtual Screening by Using a New Deep-Learning Classifier.

Journal of agricultural and food chemistry 35104412

CYP3A4 is the main human enzyme responsible for phase I metabolism of dietary compounds, prescribed drugs and xenobiotics, steroid hormones, and bile acids. The inhibition of CYP3A4 activity might impair physiological mechanisms, including the endocr...

Cytochrome P-450 CYP3A Cytochrome P-450 CYP3A Inhibitors Deep Learning Enzyme Inhibitors Humans Xenobiotics

View on PubMed DOI

An Uncertainty-Guided Deep Learning Method Facilitates Rapid Screening of CYP3A4 Inhibitors.

Journal of chemical information and modeling 38055780

Cytochrome P450 3A4 (CYP3A4), a prominent member of the P450 enzyme superfamily, plays a crucial role in metabolizing various xenobiotics, including over 50% of clinically significant drugs. Evaluating CYP3A4 inhibition before drug approval is essent...

Cytochrome P-450 CYP3A Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Enzyme System Deep Learning Drug Interactions Enzyme Inhibitors Reproducibility of Results Uncertainty

View on PubMed DOI

Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition.

Journal of applied toxicology : JAT 38544296

Cytochrome P450 (CYP) enzymes are involved in the metabolism of approximately 75% of marketed drugs. Inhibition of the major drug-metabolizing P450s could alter drug metabolism and lead to undesirable drug-drug interactions. Therefore, it is of great...

Algorithms Computer Simulation Cytochrome P-450 CYP2C9 Cytochrome P-450 CYP2C9 Inhibitors Cytochrome P-450 CYP2D6 Cytochrome P-450 CYP2D6 Inhibitors Cytochrome P-450 CYP3A Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 Enzyme Inhibitors Deep Learning Humans Machine Learning

View on PubMed DOI

AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Physiological based pharmacokinetic modeling to estimate in vivo Ki of ketoconazole on renal P-gp using human drug-drug interaction study result of fesoterodine and ketoconazole.

Three- and four-class classification models for P-glycoprotein inhibitors using counter-propagation neural networks.

Application of Deep Neural Network Models in Drug Discovery Programs.

Dietary Inhibitors of CYP3A4 Are Revealed Using Virtual Screening by Using a New Deep-Learning Classifier.

An Uncertainty-Guided Deep Learning Method Facilitates Rapid Screening of CYP3A4 Inhibitors.

Evaluation of machine learning models for cytochrome P450 3A4, 2D6, and 2C9 inhibition.

Popular Topics

Recent Journals